Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 129,850 | reported | 03 Jan 2023 | tx 4+399,137 |
| First Tracks Biotherapeutics, Inc. | 5,000 | reported | 12 May 2026 | tx 6+188,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 13,600 | 0.00 USD | deriv |
| 21 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 45,700 | 0.00 USD | deriv |
| 21 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 41,233 | 0.00 USD | deriv |
| 22 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 41,233 | 0.00 USD | deriv |
| 23 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 41,234 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 129,850 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 111,700 | 0.00 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 56,649 | 0.00 USD | deriv |
| 12 Apr 2021 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 100,938 | 0.00 USD | deriv |